AU9245398A - Preparation for the therapy of disorders related to blood clotting - Google Patents

Preparation for the therapy of disorders related to blood clotting

Info

Publication number
AU9245398A
AU9245398A AU92453/98A AU9245398A AU9245398A AU 9245398 A AU9245398 A AU 9245398A AU 92453/98 A AU92453/98 A AU 92453/98A AU 9245398 A AU9245398 A AU 9245398A AU 9245398 A AU9245398 A AU 9245398A
Authority
AU
Australia
Prior art keywords
therapy
preparation
blood clotting
disorders related
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU92453/98A
Inventor
Hans-Peter Doz. Schwarz
Peter Turecek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Publication of AU9245398A publication Critical patent/AU9245398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU92453/98A 1997-09-19 1998-09-21 Preparation for the therapy of disorders related to blood clotting Abandoned AU9245398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0159597A ATA159597A (en) 1997-09-19 1997-09-19 PREPARATION FOR TREATING BLOOD COagulation disorders
AT1595/97 1997-09-19
PCT/AT1998/000228 WO1999015197A1 (en) 1997-09-19 1998-09-21 Preparation for the therapy of disorders related to blood clotting

Publications (1)

Publication Number Publication Date
AU9245398A true AU9245398A (en) 1999-04-12

Family

ID=3516826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU92453/98A Abandoned AU9245398A (en) 1997-09-19 1998-09-21 Preparation for the therapy of disorders related to blood clotting

Country Status (3)

Country Link
AT (1) ATA159597A (en)
AU (1) AU9245398A (en)
WO (1) WO1999015197A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102351953B (en) * 2003-12-01 2017-05-10 诺和诺德医疗保健公司 Virus filtration of liquid Factor VII compositions
AT506216B1 (en) * 2008-02-13 2009-07-15 Peter Dr Hernuss COMPOSITION FOR RECORDING MUCOSES TISSUE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510248A (en) * 1993-06-22 1996-04-23 The University Of British Columbia Stable recombinant meizothrombin-like polypeptides
DE19531637A1 (en) * 1995-08-28 1997-03-06 Immuno Ag Pharmaceutical composition for the treatment of blood coagulation disorders, method for the production thereof and their use
AT404597B (en) * 1995-11-24 1998-12-28 Immuno Ag PROCESS FOR PRODUCING PROTEINS
DE59712322D1 (en) * 1996-03-20 2005-06-30 Baxter Ag Pharmaceutical preparation for the treatment of blood clotting disorders
DE59800935D1 (en) * 1997-04-08 2001-08-02 Baxter Ag Immuntolerante prothrombinkomplex-präparation

Also Published As

Publication number Publication date
WO1999015197A1 (en) 1999-04-01
ATA159597A (en) 2000-09-15

Similar Documents

Publication Publication Date Title
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
AU1520699A (en) Methods for treatment of disorders of cardiac contractility
IL121170A0 (en) Compositions for the treatment of dermatological disorders
AU3920900A (en) Compounds and methods to treat cardiac failure and other disorders
AU4525396A (en) Process for the preparation of perfluorocarbons
EP1063990A4 (en) Therapy of estrogen-associated disorders
FI952169A (en) Stable preparation for the treatment of clotting disorders of the blood
AU2762395A (en) Process for the preparation of azanoradamantane benzamides
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
GB2361872B (en) Diagnosis of medical disorders
AU2739497A (en) Use of vitamin d analogs for the treatment of arthritic disease
AU7106300A (en) Treatment of skin disorders
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU9245398A (en) Preparation for the therapy of disorders related to blood clotting
AU8842798A (en) Process for the preparation of ivermectin
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU7920198A (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
AU2037800A (en) Diagnosis of human glycosylation disorders
AU1931895A (en) Treatment of graft-versus-host disease
IL135171A0 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
AU7944498A (en) System for applying a therapeutic action to the organism of a patient
AU4596097A (en) Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives
AU5503090A (en) Imidazodiazepines for the treatment of neurological symptons
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase